ADAR, adenosine deaminase; ADF, adefovir; AG, antigenomic; Actb, actin beta; Antiviral; BSA, bovine serum albumin; CHD, chronic hepatitis D; CK18, cytokeratin 18; CXCL10, C-X-C motif chemokine ligand 10; Eef2, eukaryotic elongation factor; FCS, foetal calf serum; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Genotype; HBsAg, hepatitis B virus surface antigen; HDAg, hepatitis delta antigen (S, small, L, large); HDV; HLA, human leucocyte antigen; HSA, uman serum albumin; Human liver chimeric mice; IFNα, interferon α; ISGs, interferon stimulated genes; LAM, lamivudine; LLoD, lower limit of detection; MDA5, melanoma differentiation-associated protein 5; MOI, multiplicity of infection; Mavs, mitochondrial antiviral-signalling protein; MoA, mode of action; MxA, myxovirus resistance gene A; NTCP, sodium (Na+) taurocholate co-transporting polypeptide; NUCs, nucleos(t)ide analogues; OAS1, 2'-5'-oligoadenylatsynthetase 1; PEG, polyethylene glycol; PHHs, primary human hepatocytes; RNP, ribonucleoprotein; Resistance; Rig-I, retinoic acid-inducible gene I; SCID, severe combined immunodeficiency; STAT1, signal transducers and activators of transcription 1; TGFß, transforming growth factor-ß; USG, uPA/SCID/beige/IL2RG-/-; casp, caspase; hAAT, human alpha antitrypsin; pegIFNα, pegylated interferon alpha; pgRNA, pregenomic RNA; qPCR, quantitative real time polymerase chain reaction; uPA, urokinase plasminogen activator